Your browser doesn't support javascript.
loading
In vitro activity of the novel Fe-cyclam complex against clinical multidrug-resistant bacterial isolates from Brazil.
Polo, Ana B; Lemos, Ari So; Martins da Mata, Camila Ps; Oliveira, Verônica S; Pontes, Ana Cfb; Pontes, Daniel L; Tavares, Guilherme D; Fabri, Rodrigo L; M Apolônio, Ana Carolina.
Afiliação
  • Polo AB; Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, 36036-900, Brazil.
  • Lemos AS; Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, 36036-900, Brazil.
  • Martins da Mata CP; Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, 31270-901, Brazil.
  • Oliveira VS; Institute of Chemistry, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59078-970, Brazil.
  • Pontes AC; Institute of Chemistry, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59078-970, Brazil.
  • Pontes DL; Institute of Chemistry, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, 59078-970, Brazil.
  • Tavares GD; Laboratory of Nanostructured Systems Development, Department of Pharmaceutical Science, Faculty of Pharmacy, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, 36036-900, Brazil.
  • Fabri RL; Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, 36036-900, Brazil.
  • M Apolônio AC; Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, 36036-900, Brazil.
Future Microbiol ; 18: 897-909, 2023 09.
Article em En | MEDLINE | ID: mdl-37584550
ABSTRACT

Aim:

To evaluate the effect of a new Fe-cyclam complex on pathogenic bacterial species, including multidrug-resistant clinical specimens. Materials &

methods:

The complex [Fe(cyclam)ox]PF6 (D2) was tested in cytotoxicity and MIC tests. Clinical and reference strains of Gram-negative and Gram-positive bacteria were used. Considering Staphylococcus aureus strains, the profile of antimicrobial susceptibility and time-kill kinetics for D2 was performed. An in silico analysis for D2 was also performed.

Results:

D2 showed broad bacterial activity, mainly against specimens of Cutibacterium acnes, S. aureus, Pseudomonas aeruginosa and Acinetobacter baumannii. Low cytotoxicity in human cells was demonstrated.

Conclusion:

The tested compound proved to be a promising agent against resistant bacterial infections.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acinetobacter baumannii / Antibacterianos Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acinetobacter baumannii / Antibacterianos Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Ano de publicação: 2023 Tipo de documento: Article